Scancell Holdings PLC
LSE:SCLP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Scancell Holdings PLC
LSE:SCLP
|
UK |
Intrinsic Value
The intrinsic value of Scancell Holdings PLC (SCLP) under the Base Case is 20.28 GBX per share.
Compared with the current market price of 89 GBX, the stock appears
Overvalued by 77% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Scancell Does
Scancell Holdings is a UK biotechnology company focused on making new cancer treatments, especially immunotherapies that help the body’s immune system find and attack tumors. Its main work is developing drug candidates in the lab and through clinical trials rather than selling finished medicines today. The company is built around a small number of proprietary platforms, including programs aimed at cancer and some infectious disease targets.
- Headquarters
- United Kingdom UK
- Employees
- 60
- IPO date
- Jul 30, 2010
Earnings Waterfall
Scancell Holdings PLC
The intrinsic value for Scancell Holdings PLC (SCLP) under the Base Case is 20.28 GBX.
Compared with the current market price of 89 GBX, the stock appears Overvalued by 77% .